Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
0.95
-0.055 (-5.47%)
Range 0.90 - 0.9601
Open 0.95
Prev Close 1.005
52 Week 0.90 - 2.45
Volume 20500368
Market Cap 489.1M
*Delayed 11/21/2014 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000